SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 46 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $288,000 | – | 400,000 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Boxer Capital, LLC | 2,125,000 | $5,780,000 | 0.62% |
RA Capital Management | 2,471,456 | $6,722,000 | 0.52% |
DAFNA Capital Management LLC | 373,702 | $1,016,000 | 0.49% |
BVF INC/IL | 1,684,636 | $4,582,000 | 0.46% |
OIKOS HOLDINGS LLC | 182,395 | $496,000 | 0.39% |
Eventide Asset Management | 2,265,455 | $6,162,000 | 0.29% |
Telemetry Investments, L.L.C. | 175,000 | $476,000 | 0.18% |
NEA Management Company, LLC | 1,298,274 | $3,531,000 | 0.16% |
Rhenman & Partners Asset Management AB | 450,100 | $1,224,000 | 0.15% |
Palo Alto Investors LP | 1,162,473 | $3,162,000 | 0.14% |